Classic ketogenic diet-induced ketoacidosis in the treatment of pyruvate dehydrogenase deficiency: a case report and literature review
- PMID: 39342148
- PMCID: PMC11438371
- DOI: 10.1186/s12887-024-05054-w
Classic ketogenic diet-induced ketoacidosis in the treatment of pyruvate dehydrogenase deficiency: a case report and literature review
Abstract
Background: As a rare mitochondrial disorder, the pyruvate dehydrogenase complex (PDC) deficiency is a rare inborn disease characterized with glucose metabolism defects, which leads to neurological dysfunction, serum lactic acid buildup and a resultant trend of metabolic acidosis. Although the ketogenic diet (KD) is the first-line treatment for PDC deficiency, there is currently no widely accepted consensus on specific implementation of KD for this condition. Due to the combined effect of pre-existing hyperlactacidemia and KD-induced ketoacidosis that can further exacerbate metabolic disturbances, maintaining metabolic homeostasis should be prioritized during the implementation of KD.
Case presentation: Herein, the authors present a 6-year-old boy with lactic acidosis, ataxia, hypotonia and neuromotor development retardation. The KD was started after the patient was diagnosed with PDC deficiency based on genetic testing. The initiation with classic KD resulted in severe non-diabetic ketoacidosis with elevated anion gap, which was promptly alleviated by dextrose supplementation and dietary modification to a less-restrictive KD. Long-term supervision demonstrated the efficacy of a modified KD in improving both clinical course and metabolic acidosis of the patient.
Conclusions: This rare case adds to the limited evidence of KD application in PDC deficiency, and provides valuable insights into the importance of reasonably lowering the ketogenic ratio of KD at the start of treatment to reduce the risk of metabolic acidosis.
Keywords: Acidosis; Ketogenic diet; Lactic acid; Non-diabetic ketoacidosis; Pyruvate dehydrogenase complex deficiency.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Reconciling diabetes management and the ketogenic diet in a child with pyruvate dehydrogenase deficiency.J Child Neurol. 2006 May;21(5):436-9. doi: 10.1177/08830738060210051001. J Child Neurol. 2006. PMID: 16901455
-
The first case with FBXL4 mutation successfully treated with a parenteral ketogenic diet for lactic acidosis.JPEN J Parenter Enteral Nutr. 2021 Nov;45(8):1788-1792. doi: 10.1002/jpen.2121. Epub 2021 May 25. JPEN J Parenter Enteral Nutr. 2021. PMID: 33882172
-
Intravenous ketogenic diet therapy for neonatal-onset pyruvate dehydrogenase complex deficiency.Brain Dev. 2022 Mar;44(3):244-248. doi: 10.1016/j.braindev.2021.11.005. Epub 2021 Dec 1. Brain Dev. 2022. PMID: 34863613
-
The use of ketogenic diets in children living with drug-resistant epilepsy, glucose transporter 1 deficiency syndrome and pyruvate dehydrogenase deficiency: A scoping review.J Hum Nutr Diet. 2024 Aug;37(4):827-846. doi: 10.1111/jhn.13324. Epub 2024 Jun 4. J Hum Nutr Diet. 2024. PMID: 38838079
-
Pyruvate dehydrogenase deficiency: morphological and metabolic effects, creation of animal model to search for curative treatment.Folia Morphol (Warsz). 2020;79(2):191-197. doi: 10.5603/FM.a2020.0020. Epub 2020 Feb 19. Folia Morphol (Warsz). 2020. PMID: 32073132 Review.
Cited by
-
The Ketogenic Diet in Obesity Management: Friend or Foe?Cell Biochem Biophys. 2025 Aug 29. doi: 10.1007/s12013-025-01878-0. Online ahead of print. Cell Biochem Biophys. 2025. PMID: 40879882 Review.
References
-
- Lee PR, Kossoff EH. Dietary treatments for epilepsy: management guidelines for the general practitioner. Epilepsy Behav. 2011;21(2):115–21. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous